key: cord-0725871-m1hu7p96
authors: Cutler, Todd; Scales, David; Levine, William; Schluger, Neil; O’Donnell, Max
title: A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis
date: 2020-09-01
journal: Am J Respir Crit Care Med
DOI: 10.1164/rccm.202003-0828im
sha: cfffc65bf7038b8dcad26adec968b8e7dd63f85d
doc_id: 725871
cord_uid: m1hu7p96

nan

. Portable anteroposterior chest radiograph on hospital Day 1 demonstrating left lower lung opacities and moderate effusion with atelectasis/consolidation (*).

A 61-year-old man with a history of Parkinson's disease presented with a history of 4 days of cough and fever to an emergency department in New York City. He described acute high-grade fever and cough with a background of 4 months of cough with occasional blood-streaked sputum. He was a New York City resident originally from China; he reported no known sick contacts or recent travel. Chest radiograph demonstrated a dense left basilar opacity (Figure 1 ), and pointof-care ultrasound revealed a left pleural effusion with compressive atelectasis (Video E1 in the online supplement). Patient was placed in respiratory and contact isolation because of concern about coronavirus disease (COVID-19) as well as tuberculosis (TB). Initial workup included a nasal pharyngeal swab, which tested positive by RT-PCR for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Complete blood count revealed lymphopenia (absolute lymphocyte count 935 cells/ml), and other routine laboratory values were within normal limits. A thoracentesis was performed, and 1.5 L of bloody, lymphocyte-predominant pleural fluid was removed. Sputum stained for acid-fast bacilli revealed moderate mycobacteria, and Gene-Xpert MTB/RIF sputum assay confirmed Mycobacterium tuberculosis.

The patient was initiated on hydroxychloroquine for putative antiviral activity against SARS-CoV-2 and started on standard isoniazid, rifampin, ethambutol, and pyrazinamide for TB treatment. Initially, he required nasal canula oxygen supplementation at 2 L/min to maintain a normal oxygen saturation. Over time, the patient improved clinically: his supplemental oxygen requirements resolved, sputum acid-fast stain for bacilli converted to negative 33, repeat nasopharyngeal swab RT-PCR for SARS-CoV-2 was negative, and he was successfully discharged to home to complete his TB treatment course.

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Clinical and immunological features of severe and moderate coronavirus disease 2019

Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity